Joseph Nixon

Finanzdirektor/CFO bei Locus Biosciences, Inc.

Consumer Services

Commercial Services

Technology Services

Profil

Joseph Nixon is currently the Director at Bioaesthetics Corp.
and the Chief Financial Officer at Locus Biosciences, Inc. He received his undergraduate degree from Case Western Reserve University and his MBA from Harvard Business School.

Aktive Positionen von Joseph Nixon

Unternehmen	Position	Beginn
Bioaesthetics Corp. Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA.	Direktor/Vorstandsmitglied	23.08.2023
Locus Biosciences, Inc. Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC.	Finanzdirektor/CFO	-

Alle aktiven Positionen von Joseph Nixon

Ausbildung von Joseph Nixon

Case Western Reserve University	Undergraduate Degree
Harvard Business School	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Joseph Nixon im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Bioaesthetics Corp. Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA.	Commercial Services
Locus Biosciences, Inc. Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC.	Technology Services